Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13358805 | 1.00 | ALOX15 (0.37) | ALOX15CYP1B1ALDH1A1CYP19A1CYP2C19 | |
| SCHEMBL18429828 | 1.00 | ALOX15 (0.37) | ALOX15CYP1B1ALDH1A1CYP19A1CYP2C19 | |
| SCHEMBL5796929 | 0.76 | CYP1A2 (0.46) | ALOX15ALDH1A1CYP19A1CYP2C19EPHX1 | |
| SCHEMBL19035390 | 0.74 | APLNR (0.36) | ALOX15CYP1B1ALDH1A1CYP2C19L3MBTL1 | |
| SCHEMBL25982586 | 0.73 | ALOX15 (0.34) | ALOX15CYP1B1ALDH1A1L3MBTL1 | |
| SCHEMBL587891 | 0.73 | SMN1; SMN2 (0.33) | EPHX1 | |
| SCHEMBL7877932 | 0.72 | CYP2C19 (0.35) | ALOX15CYP1B1ALDH1A1CYP2C19L3MBTL1 | |
| SCHEMBL20002231 | 0.71 | EPHX1 (0.34) | CYP19A1EPHX1 | |
| SCHEMBL25136746 | 0.71 | ALOX15 (0.36) | ALOX15CYP1B1ALDH1A1L3MBTL1 | |
| SCHEMBL14401882 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017027363-A1 | SPEARMINT FLAVOR ENHANCER | PINOVA HOLDINGS, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
| US-20170035079-A1 | SPEARMINT FLAVOR ENHANCER | SYMRISE INC. | 2017-02-09 | — | — | US | disclosed |
| US-20170035079-A1 | SPEARMINT FLAVOR ENHANCER | SYMRISE INC. | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170035079-A1 | SPEARMINT FLAVOR ENHANCER | DLAT, CRAT, LCAT | ALOX15 1264/4885CYP1B1 2705/4885ALDH1A1 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.